Invivyd IVVD
NASDAQ IVVD
$0.65 +0.01 (+1.40%)
As of: Oct 21, 2026 · 3:40 PM EDT

Invivyd (IVVD) EBT Margin (2024 - 2026)

Updated

Invivyd (IVVD) reported EBT Margin of -320.76% for Q2 2026, down 192.98 percentage points from -127.78% a year earlier.

Analysis

Invivyd (IVVD) EBT Margin (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Invivyd's EBT Margin came in at -149.73%, up 95.94 percentage points year-over-year; for FY2025, it was -103.99%, up 592.81 percentage points from FY2024.

  • By year, EBT Margin came in at -696.80% in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly EBT Margin since Q3 2024.
  • Year over year, EBT Margin gained in three of the last four quarters, with an average year-over-year change of +626.67 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn 26.66%
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn 25.18%
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn 18.19%
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn 27.53%
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn -131.41%
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn -4.34%
10 Invivyd 206.42 Mn -300.22 Mn 13.01 Mn -320.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -320.76%
Dec 31, 2025 -72.96%
Sep 30, 2025 -83.96%
Jun 30, 2025 -127.78%
Mar 31, 2025 -149.70%
Dec 31, 2024 -139.14%
Sep 30, 2024 -670.01%
Jun 30, 2024 -2,175.22%
API Access

Invivyd EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY